Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

EGCG

  • You have access
    Epigallocatechin Gallate Inhibits Cell Growth and Hedgehog Signalling in Human Rhabdomyosarcoma Cell Lines
    BENJAMIN F.B. MAYER, MATIAS J. STAGNO, JÖRG FUCHS, STEVEN W. WARMANN and EVI SCHMID
    Anticancer Research March 2023, 43 (3) 1025-1030; DOI: https://doi.org/10.21873/anticanres.16247
  • You have access
    Epigallocatechin-3-gallate Enhances Radiation Sensitivity in Colorectal Cancer Cells Through Nrf2 Activation and Autophagy
    TUMENJIN ENKHBAT, MASAAKI NISHI, KOZO YOSHIKAWA, HIGASHIJIMA JUN, TAKUYA TOKUNAGA, CHIE TAKASU, HIDEYA KASHIHARA, DAICHI ISHIKAWA, MASAHIDE TOMINAGA and MITSUO SHIMADA
    Anticancer Research November 2018, 38 (11) 6247-6252; DOI: https://doi.org/10.21873/anticanres.12980
  • You have access
    (–)-Epigallocatechin-3-gallate Down-regulates Doxorubicin-induced Overexpression of P-glycoprotein Through the Coordinate Inhibition of PI3K/Akt and MEK/ERK Signaling Pathways
    HANA SATONAKA, KUMIKI ISHIDA, MIHO TAKAI, RYOJI KOIDE, RYOTA SHIGEMASA, JUN UEYAMA, TETSUYA ISHIKAWA, KAZUHIKO HAYASHI, HIDEMI GOTO and SHINYA WAKUSAWA
    Anticancer Research November 2017, 37 (11) 6071-6077;
  • You have access
    Curcumin and Epigallocatechin Gallate Inhibit the Cancer Stem Cell Phenotype via Down-regulation of STAT3–NFκB Signaling
    SEYUNG S. CHUNG and JAYDUTT V. VADGAMA
    Anticancer Research January 2015, 35 (1) 39-46;
  • You have access
    Green Tea Polyphenol Epigallocatechin 3-Gallate, Contributes to the Degradation of DNMT3A and HDAC3 in HCT 116 Human Colon Cancer Cells
    VONDINA R. MOSELEY, JAY MORRIS, REBECCA W. KNACKSTEDT and MICHAEL J. WARGOVICH
    Anticancer Research December 2013, 33 (12) 5325-5333;
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire